A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Clinical trial NCT00485563 · TERMINATED

Trial details

NCT number: NCT00485563
Sponsor: Endocyte
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2007-06-01
Primary completion: 2008-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.